- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Demonstrate that treatment with degarelix in terms of mean percentage reduction in prostate volume measured with trans-rectal ultrasound (TRUS) is non-inferior to treatment with goserelin plus bicalutamide at 12 weeks compared to baseline
Critère d'inclusion
- Prostate cancer